Kymera Therapeutics (KYMR) Other Gross PP&E Adjustments (2019 - 2025)
Historic Other Gross PP&E Adjustments for Kymera Therapeutics (KYMR) over the last 7 years, with Q3 2025 value amounting to $22.4 million.
- Kymera Therapeutics' Other Gross PP&E Adjustments rose 6130.68% to $22.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.4 million, marking a year-over-year increase of 6130.68%. This contributed to the annual value of $16.4 million for FY2024, which is 82625.35% up from last year.
- As of Q3 2025, Kymera Therapeutics' Other Gross PP&E Adjustments stood at $22.4 million, which was up 6130.68% from $19.3 million recorded in Q2 2025.
- In the past 5 years, Kymera Therapeutics' Other Gross PP&E Adjustments registered a high of $22.4 million during Q3 2025, and its lowest value of -$33.7 million during Q1 2023.
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was $7.2 million (2022), whereas its average is $4.5 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first plummeted by 76314.75% in 2023, then skyrocketed by 82625.35% in 2024.
- Over the past 5 years, Kymera Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $5.0 million in 2021, then soared by 88.68% to $9.3 million in 2022, then plummeted by 81.01% to $1.8 million in 2023, then soared by 826.25% to $16.4 million in 2024, then soared by 36.49% to $22.4 million in 2025.
- Its Other Gross PP&E Adjustments was $22.4 million in Q3 2025, compared to $19.3 million in Q2 2025 and $17.0 million in Q1 2025.